These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35695267)
1. Cost-effectiveness analysis of continuous subcutaneous insulin infusion versus multiple daily insulin for treatment of children with type 1 diabetes. Zhang L; Leng X; Tian F; Xiao D; Xuan J; Yang H; Liu J; Chen Z Postgrad Med; 2022 Aug; 134(6):627-634. PubMed ID: 35695267 [TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT. Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847 [TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China. Hu S; Yang H; Chen Z; Leng X; Li C; Qiao L; Lv W; Li T Front Endocrinol (Lausanne); 2021; 12():604028. PubMed ID: 33859614 [TBL] [Abstract][Full Text] [Related]
4. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada. St Charles ME; Sadri H; Minshall ME; Tunis SL Clin Ther; 2009 Mar; 31(3):657-67. PubMed ID: 19393856 [TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia. Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808 [TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation. Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C; BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands. Roze S; Duteil E; Smith-Palmer J; de Portu S; Valentine W; de Brouwer BF; Reznik Y; de Valk HW J Med Econ; 2016 Aug; 19(8):742-9. PubMed ID: 26985982 [TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes]. Nørgaard K; Sohlberg A; Goodall G Ugeskr Laeger; 2010 Jul; 172(27):2020-5. PubMed ID: 20594535 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review. Roze S; Smith-Palmer J; Valentine W; de Portu S; Nørgaard K; Pickup JC Diabet Med; 2015 Nov; 32(11):1415-24. PubMed ID: 25962621 [TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective. St Charles M; Lynch P; Graham C; Minshall ME Value Health; 2009; 12(5):674-86. PubMed ID: 19171006 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security. Doubova SV; Roze S; Ferreira-Hermosillo A; Pérez-Cuevas R; Gasca-Pineda R; Barsoe C; Baran J; Ichihara B; Gryzbowski E; Jones K; Valencia JE Cost Eff Resour Alloc; 2019; 17():19. PubMed ID: 31507338 [TBL] [Abstract][Full Text] [Related]
13. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective. Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389 [TBL] [Abstract][Full Text] [Related]
14. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855 [TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland. Roze S; Smith-Palmer J; Delbaere A; Bjornstrom K; de Portu S; Valentine W; Honkasalo M Diabetes Ther; 2019 Apr; 10(2):563-574. PubMed ID: 30730036 [TBL] [Abstract][Full Text] [Related]
16. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands. Serné EH; Roze S; Buompensiere MI; Valentine WJ; De Portu S; de Valk HW Adv Ther; 2022 Apr; 39(4):1844-1856. PubMed ID: 35226346 [TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey. Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715 [No Abstract] [Full Text] [Related]
19. Use of continuous subcutaneous insulin infusion versus multiple daily injections in emerging adults with type 1 diabetes is associated with better clinical engagement but not glycaemic control. Chai TYL; Farrell K; Holmes-Walker DJ Intern Med J; 2023 Feb; 53(2):255-261. PubMed ID: 34561942 [TBL] [Abstract][Full Text] [Related]
20. Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model. Zöllner YF; Ziegler R; Stüve M; Krumreich J; Schauf M J Diabetes Sci Technol; 2016 Sep; 10(5):1142-8. PubMed ID: 26902790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]